Cargando…

MON-196 Gender-Affirming Hormonal Therapy and Incidence of Metabolic Syndrome and Cardiovascular Events in Patients with Gender Dysphoria

Background: Long-term effects of gender-affirming hormonal therapy (GAHT) on cardiovascular risk factors and metabolic syndrome (MS) is currently unclear. Particularly, the effect of GAHT on cardiovascular outcomes in older individuals (>60 years) with gender dysphoria (GD) is unknown. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mok, Mary, Pinkson, Sheila, Case, Emina, Bruder, Jan, Koops, Maureen, Tripathy, Devjit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550827/ http://dx.doi.org/10.1210/js.2019-MON-196

Ejemplares similares

SUN-044 Gonadotropin Releasing Hormone (GnRH) Agonist Therapy Induces a Sustained Reduction in Plasma Testosterone Levels and Is Well Tolerated in Transwomen Veterans
por: Gondin, Lyan, et al.
Publicado: (2020)

MON-195 Trans-transgender Female: Gender Identity Reversal Following Irreversible Gender Affirming Surgeries
por: Korpaisarn, Sira, et al.
Publicado: (2019)

Magnetic Resonance Spectroscopy in Gender Dysphoria
por: Collet, Sarah Marie, et al.
Publicado: (2021)

ODP414 Incidence of Suicidal Events in Transgender Patients with Initiation of Gender Affirming Hormone Therapy
por: Elliott, Karma-Jaya, et al.
Publicado: (2022)

OR31-05 Long-Term Effects Of Gender Affirming Hormone Therapy On Insulin Sensitivity, Insulin Secretion, And Glucose Tolerance
por: Pinkson, Sheila, et al.
Publicado: (2023)

Effect on Kidney Function During Gender Affirming Hormonal Treatment in Transgender Individuals
por: Maheshwari, Arvind Kumar, et al.
Publicado: (2021)

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021)

SUN-051 Gender Dysphoria - Data from One Hundred Patients
por: Ferreira, Maria João, et al.
Publicado: (2020)

LBODP091 The Reasons For Loss To Follow-up Of Patients With Gender Dysphoria
por: Kadioglu, Pinar, et al.
Publicado: (2022)

SAT422 Gender Affirming Hormone Therapy in a Non-Binary Individual with Swyer Syndrome
por: Yohannan, Jiby M, et al.
Publicado: (2023)

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
por: Da Silva, Eliane Dias, et al.
Publicado: (2021)

PMON280 Effect of Gender Affirming Hormone Therapy (GAHT) on Adipose Tissue Morphology and Metabolism in Transgender Individuals
por: Shah, Manasi S, et al.
Publicado: (2022)

Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study
por: Foster Skewis, Lucas, et al.
Publicado: (2021)

Cardiovascular Risk Factors in Transgender Women Undergoing Long-Term Gender-Affirming Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

ODP415 Inclusion Health Clinic: Gender-Affirming Hormone Therapy & Surgery Booklet and Review of Efficacy in Patient-Provider Encounters
por: Pulsiano, Sune Wolf, et al.
Publicado: (2022)

“It Wasn’t for the Sake of Me and My Mental Health”: Transgender People’s Perspective on the Role of Mental Health Providers in Initiating Gender-Affirming Hormones - a Qualitative Study
por: Maksutova, Mariam, et al.
Publicado: (2021)

RF34 | PMON276 The Effect of Gender Affirming Hormone Therapy (GAHT) on Non-Conventional Cardiovascular Risk Markers in Transgender Men: A Systematic Review
por: Moreira Allgayer, Roberta Martins Costa, et al.
Publicado: (2022)

Abstract 65: Effects of gender affirming hormone therapy on metabolic health and body composition in gender dysphoria
por: Kiran, Baratam Hari, et al.
Publicado: (2022)

OR25-4 Modulatory Effects of Estradiol on the Resting-State Functional Connectivity in Transwomen Following Gender Affirming Surgery
por: Schneider, Maiko, et al.
Publicado: (2019)

MON-649 Application of the New Cluster-Based Classification of Adult Onset Diabetes in a South Texas Veteran Population
por: Trejo, Jonathan, et al.
Publicado: (2020)

Sexual & reproductive health information on minor consent forms for pubertal suppression and gender affirming hormones
por: Taylor, Julia, et al.
Publicado: (2023)

Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021)

Abstract 200: Gender Affirming Female To Male Top Surgery: An Effective Treatment For Gender Dysphoria?
por: Mulloy, Clairissa D., et al.
Publicado: (2020)

Age at First Experience of Gender Dysphoria Among Transgender Adults Seeking Gender-Affirming Surgery
por: Zaliznyak, Michael, et al.
Publicado: (2020)

The Gender Affirmative Treatment Model for Youth with Gender Dysphoria: A Medical Advance or Dangerous Medicine?
por: Clayton, Alison
Publicado: (2021)

Gender Dysphoria – Prevalence and Co-Morbidities in an Irish Adult Population
por: Judge, Ciaran, et al.
Publicado: (2014)

MON-194 Multidisciplinary Care for Adult Transgender/Gender Non-binary Patients: A Novel Healthcare Delivery Model Centered within the Endocrinology Clinic
por: Iwamoto, Sean, et al.
Publicado: (2019)

OR25-4 Active Testosterone Treatment Impairs In Vitro Fertilization (IVF) Outcomes in a Female Mouse Model for Gender-Affirming Testosterone with Improvement in Outcomes Following Cessation of Testosterone Treatment
por: Moravek, Molly B, et al.
Publicado: (2022)

SAT-196 Maternal immunity: Preimplantation Preparation
por: Elbert, Ashleigh, et al.
Publicado: (2019)

SUN-196 Generation of Potent Inhibin Analogues
por: Goney, Monica, et al.
Publicado: (2019)

Heterogeneity in gender dysphoria in a Brazilian sample awaiting gender-affirming surgery: a data-driven analysis
por: Silva, Dhiordan Cardoso, et al.
Publicado: (2022)

Gender-affirming Surgery Improves Mental Health Outcomes and Decreases Anti-depressant Use in Patients with Gender Dysphoria
por: Chou, Jesse, et al.
Publicado: (2023)

ODP148 GENDER AFFIRMING HORMONE THERAPY AND SPONTANEOUS CORONARY ARTERY DISSECTION
por: Yogeswaran, Vidhushei, et al.
Publicado: (2022)

MON-LB040 Correlation Between Length of Hormone Therapy and Adverse Events in Transgender Veterans
por: Elliott, Karma-Jaya, et al.
Publicado: (2019)

MON-016 Neural Circuits and Hormonal Mechanisms Underlying the Negative Impact of Stress on Pregnancy Outcomes
por: Gotlieb, Neta, et al.
Publicado: (2020)

Presentation of gender dysphoria: A perspective from Eastern India
por: Sanyal, Debmalya, et al.
Publicado: (2016)

Gender-Affirming Hormone Therapy: Physical and Sociopsychological Effects, Impact and Satisfaction
por: Santos, Rafael B, et al.
Publicado: (2023)

A Cross Sectional Analysis of the Prevalence of Co-Morbidities in Older Transgender Individuals Receiving Hormone Affirming Therapy in Comparison With the General Population
por: Breda, Ido, et al.
Publicado: (2021)

MON-197 Peri-operative Outcomes of Vaginoplasty Using an Individualized Approach to Hormone Management in Transgender Women
por: Davidge-Pitts, Caroline, et al.
Publicado: (2019)

MON-009 GLUT1-Mediated Glycolysis Facilitates GnRH-Induced Secretion of Luteinizing Hormone
por: Nicholas, Dequina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gl1igcht4tmhd7anps3kj62bka